CMA again accuses Advanz of pharma collusion
The UK’s competition watchdog has issued a fourth statement of objections against Advanz Pharma, now accusing the drugmaker and two others of carving up the market for the antibiotic Nitrofurantoin.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10